Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

ING GROEP N.V. 7.05 NG PERPETUAL DEBT SECURITIES (NY: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close -
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cannabis Science to Begin In-House Clinical Research With IGXBio's GenePro FDA Investigational New Drug (IND) Number 015982 for further Drug Development to Identify & Develop Agonist Cannabinoids for
From NewMediaWire
MMJ BioScience Files Pre Investigational New Drug (IND) Application With FDA For Pharmaceutical Cannabidiol (CBD) derived medicine.
Tags Health: Other Business Health: Supporting Products and Services
From PRWeb

Performance

More News

Read More
Positive Cannabinoid Testing Data in California Prompts Cannabis Science Lab Expansions for IGXBio's GenePro FDA Investigational New Drug (IND) Number 015982 for Further Drug Development to Identify &
From NewMediaWire
Ascentage Approved to Start China Trial of Apoptosis Drug
From ChinaBio® Today
UPDATE 2-U.S. stores far from overwhelmed as Black Friday sales begin
Tags companyNews
From Reuters: Company News
Tarrex Biopharma, a US-China Startup, Approved to Start US Cancer Drug Trial
From ChinaBio® Today
BRIEF-Oragenics - expects to file an investigational new drug (IND) update and initiate a phase 2 study with AG013 in United States and Europe in early 2017
Tags companyNews
From Reuters: Company News
BRIEF-Oragenics - expects to file an investigational new drug (IND) update and initiate a phase 2 study with AG013 in United States and Europe in early 2017
Tags 10000000 07000000 OGEN,XON,
From Reuters: Company News
BRIEF-Rigel Pharmaceuticals expects to file an investigational new drug application (IND) with FDA for its first IRAK inhibitor in 2017
Tags companyNews
From Reuters: Company News
BRIEF-Rigel Pharmaceuticals expects to file an investigational new drug application (IND) with FDA for its first IRAK inhibitor in 2017
Tags 07000000 04002006 companyNews
From Reuters: Company News
Ariad Announces FDA Has Given Clearance To Begin Clinical Development Trial
Tags ARIA AP32788 ARIAD Pharmaceuticals
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.